英文摘要 |
The aim of this study is to develop and apply the monoclonal antibodies (mAbs) against the hybrid tilapia macrophage (Oreochromis niloticus×Oreochromis mossambicus). There are a limited number of mAbs against fish leukocytes have been described until today. Our study results showed that eight mAbs, mAbM1-mAbM8, produced from BALB/c mice immunized with hybrid tilapia peripheral blood monocyte derived macrophages (PBM) with adjuvant. Those mAbs have been screened from a lot of hybridoma clones by indirect ELISA. Reveal of that the antibody titers of mAbM1, mAbM2, mAbM6, and mAbM7 are higher than the others. These four mAbs reacted with PBM, HKM (head kidney macrophages), and SM (spleen mcrophages) were used to be analyzed their characterizations by the indirect immunofluorescence assay test and flow cytometry. The results suggest these four mAbs have very high binding abilities with PBM and HKM, especially mAbM6 and mAbM7. Furthermore, mAbM6 and mAbM7 are chosen for testing the cross-reactivity with peripheral blood monocyte derived macrophages from different species including eel, carp, mice, rabbit, chicken, sheep, dog, and human. The results indicate that both mAbM6 and mAbM7 have significantly higher binding abilities with PBM from eel, mice, sheep and chicken. Interestingly , the capping or ring forms of the mAbM6^+and mAbM7^+ cells are recognized and found by the confocal microscope. Therefore, we presume that both mAbs binding epitopes are on the cell surface of the macrophages. Finally, we find that our developed mAbM6 and mAbM7 mAbs could be sorted the macrophages from peripheral blood leukocytes successfully. Indeed, our mAbs could serve as a useful tool to identify fish macrophages for further studies. |